News & Updates

Obesity appears to play a major role in the activation of the renin‒angiotensin‒aldosterone system (RAAS), with a noticeable rise of angiotensin-converting enzyme (ACE) and ACE activities during childhood, reveals a recent study. In addition, sex differences are present in the association of ACE and ACE2 activities with blood pressure (BP).

Intervene early. Cumulative exposure to common cardiovascular (CV) risk factors could be a harbinger of cardiovascular disease (CVD) in future.

Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risks of respiratory and renal diseases vs dipeptidyl peptidase-4 (DPP-4) inhibitors in patients with type 2 diabetes mellitus (T2DM), researchers from the University of Hong Kong (HKU) have reported.

Body mass index (BMI) appears to be the main mediator of the association of sleep apnoea and snoring with type 2 diabetes (T2D), suggests a study.

Combination therapy with metformin and thiazolidinedione appears to be the best performing glucose-lowering medication for preventing atrial fibrillation (AF) in patients with type 2 diabetes (T2D), as shown in a study.

Time-restricted eating does not appear to be more effective than daily calorie restriction in terms of improving intrahepatic triglyceride content, body fat, and metabolic risk factors for adults with obesity and nonalcoholic fatty liver disease (NAFLD), according to a study.